IPG Photonics Announces Second Quarter 2025 Financial Results

Rhea-AI Summary

IPG Photonics (NASDAQ: IPGP) reported Q2 2025 financial results with revenue of $250.7 million, down 3% year-over-year but above expectations. The company saw its first year-over-year revenue increase since 2022, excluding divestitures. Earnings per diluted share were $0.16, down 64% from $0.45 in Q2 2024.

Key highlights include a 21% growth in other applications driven by medical and advanced applications, 14% sales growth in Asia, and emerging growth products accounting for 54% of total revenue. The company maintained a gross margin of 37.3% and reported adjusted EBITDA of $31.5 million.

For Q3 2025, IPG expects revenue between $225-255 million and adjusted EPS of $0.05-0.35, while continuing to navigate tariff challenges through its global manufacturing footprint.

Positive

• None.

Negative

• Revenue declined 3% year-over-year to $250.7 million
• Operating income dropped 99% to $0.1 million
• Net income decreased 67% to $6.6 million
• Materials processing sales declined 6% year-over-year
• European sales decreased 24% year-over-year
• Higher product costs and tariffs impacting margins

Insights

Financial Analyst

IPG Photonics shows signs of demand recovery despite posting lower YoY results, with strategic initiatives beginning to yield benefits amid tariff challenges.

IPG Photonics delivered Q2 2025 results that exceeded expectations despite ongoing challenges. Revenue of $250.7 million was down 3% year-over-year but showed sequential improvement from Q1. Importantly, excluding divestitures, this marks the company's first year-over-year revenue increase since 2022, signaling a potential turning point.

The company's profitability metrics reveal significant pressure points. Operating income collapsed 99% to just $0.1 million, with operating margin essentially at zero compared to 4.7% a year ago. Net income fell 67% to $6.6 million, resulting in diluted EPS of $0.16, down from $0.45.

The company's strategic pivot is yielding mixed results. Emerging growth products now represent 54% of total revenue, up from 51% in Q1, reflecting management's efforts to diversify beyond traditional applications. Medical and advanced applications showed encouraging growth, partially offsetting weakness in materials processing, which still accounts for 85% of total revenue but declined 6% year-over-year.

Geographic performance was notably uneven, with Asia showing strong 14% growth while Europe declined sharply by 24%. This regional disparity likely reflects both market-specific demand patterns and the impact of tariffs, which management specifically highlighted as an ongoing challenge.

The Q3 guidance of $225-255 million in revenue and $0.05-0.35 in adjusted EPS reflects continued uncertainty. However, the Q2 book-to-bill ratio of approximately one suggests stable near-term demand. Management's emphasis on adapting to tariff challenges through flexible manufacturing and supply chain adjustments will be crucial for maintaining margins, which are projected to remain under pressure at 36-38% on an adjusted basis.

Demand Recovery and Strategic Initiatives Drove Revenue Above Expectations

Book-to-Bill was Approximately One as Bookings Also Remained Strong

MARLBOROUGH, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2025.

	Three Months Ended June 30,												Six Months Ended June 30,
(In millions, except per share data and percentages)		2025				2024				Change				2025				2024				Change
Revenue	$	250.7			$	257.6				(3	)%		$	478.5			$	509.7				(6	)%
Gross margin		37.3	%			37.3	%							38.3	%			38.0	%
Operating income	$	0.1			$	12.0				(99	)%		$	1.9			$	31.1				(94	)%
Operating margin		—	%			4.7	%							0.4	%			6.1	%
Net income	$	6.6			$	20.2				(67	)%		$	10.4			$	44.3				(77	)%
Earnings per diluted share	$	0.16			$	0.45				(64	)%		$	0.24			$	0.97				(75	)%
Non-GAAP Measures*
Adjusted gross margin		37.8	%			37.5	%							38.9	%			38.2	%
Adjusted EBITDA	$	31.5			$	39.4				(20	)%		$	64.2			$	79.6				(19	)%
Adjusted earnings per diluted share	$	0.30			$	0.52				(42	)%		$	0.61			$	1.03				(41	)%

*Adjusted gross margin, adjusted EBITDA and adjusted earnings per diluted share include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this earnings release.

Management Comments

“I am happy to report that we delivered second quarter results well above expectations. Our revenue improved sequentially, driven by modest demand recovery in general industrial and e-mobility markets. Excluding the impact of a divestiture, this was our first year-over-year revenue increase since 2022. We’re making progress on our strategy to drive profitable growth with initiatives that are already yielding results. This quarter, we saw higher revenue in medical, supported by a customer win earlier in the year, and reported strong growth in advanced applications. We are also launching a directed energy system for counter-UAV applications, which we believe will unlock significant value for our customers,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. "At the same time, we have significantly strengthened our leadership team and are continuing our investments in growth opportunities."

Financial Highlights

Second quarter revenue of $251 million decreased 3% year over year due to divestitures, and was higher year over year excluding divestitures as lower sales in materials processing were offset by growth in medical and advanced applications. Changes in foreign exchange rates increased revenue growth by approximately 1%. Materials processing sales accounted for 85% of total revenue and decreased 6% year over year, as a result of divestitures and lower sales in cutting, welding and additive manufacturing applications, partially offset by higher revenue in micromachining and the cleanLASER acquisition. Other applications sales increased 21% year over year driven by higher revenue in medical and advanced applications. Emerging growth products sales accounted for 54% of total revenue, increasing from 51% in the prior quarter. By region, sales increased 14% in Asia, and decreased 4% in North America and 24% in Europe on a year-over-year basis.

GAAP gross margin of 37.3% was flat year over year as a decrease in unabsorbed expenses and lower inventory provisions were offset by higher product cost and tariffs. Adjusted EBITDA was $31.5 million and adjusted earnings per diluted share (EPS) were $0.30 in the second quarter. During the second quarter, IPG spent $15 million on capital expenditures and $30 million on share repurchases.

Business Outlook and Financial Guidance

“The second quarter book-to-bill ratio was approximately one on the higher revenue. We are seeing continued demand into the third quarter despite the uncertainty related to tariffs. We have been successfully adapting to the current operating environment and taking advantage of our flexible global manufacturing footprint and supply chain capabilities to address tariffs," concluded Dr. Gitin.

For the third quarter of 2025, IPG expects revenue of $225 million to $255 million, adjusted gross margin between 36% and 38% and operating expenses of $89 million to $91 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.05 to $0.35 and adjusted EBITDA in the range of $22 million to $36 million.

As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations, and is subject to the risks outlined in the Company's reports filed with the SEC, and assumes exchange rates relative to the U.S. dollar of euro 0.85, Japanese yen 144 and Chinese yuan 7.16, respectively.

Supplemental Financial Information

Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Second Quarter 2025 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.

Conference Call Reminder

The Company will hold a conference call today, August 5, 2025 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.

Contact

Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com

About IPG Photonics Corporation

IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.

Safe Harbor Statement

Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to our strategy to drive profitable growth, launching a directed energy system for counter-UAV applications that we believe will unlock significant value for our customers, continuing our investments in growth opportunities, continuous demand into the third quarter despite the uncertainty related to tariffs, successfully adopting to the current operating environment and taking advantage of our flexible global manufacturing footprint and supply chain capabilities to address tariffs, and statements related to revenue, adjusted gross margin and operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for third quarter of 2025. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of the business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 20, 2025) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025			2024
	(In thousands, except per share data)
Net sales	$	250,721			$	257,645			$	478,514		$	509,654
Cost of sales		157,148				161,459				295,129			315,932
Gross profit		93,573				96,186				183,385			193,722
Operating expenses:
Sales and marketing		25,552				22,487				49,982			45,485
Research and development		29,937				27,487				58,273			56,868
General and administrative		34,882				31,602				67,690			62,760
Gain on sale of assets		—				(674	)			—			(7,450	)
Loss on foreign exchange		3,098				3,244				5,509			4,919
Total operating expenses		93,469				84,146				181,454			162,582
Operating income		104				12,040				1,931			31,140
Other income, net:
Interest income, net		8,001				12,778				15,445			26,955
Other income, net		166				194				1,510			519
Total other income		8,167				12,972				16,955			27,474
Income before provision for income taxes		8,271				25,012				18,886			58,614
Provision for income taxes		1,666				4,858				8,523			14,361
Net income	$	6,605			$	20,154			$	10,363		$	44,253
Net income per share:
Basic	$	0.16			$	0.45			$	0.24		$	0.97
Diluted	$	0.16			$	0.45			$	0.24		$	0.97
Weighted average common shares outstanding:
Basic		42,481				44,918				42,543			45,439
Diluted		42,577				45,012				42,720			45,601

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
	June 30,				December 31,
		2025				2024
	(In thousands, except share and per share data)
ASSETS
Current assets:
Cash and cash equivalents	$	359,184			$	620,040
Short-term investments		540,414				310,152
Accounts receivable, net		201,038				171,131
Inventories		303,841				284,780
Prepaid income taxes		28,813				17,592
Prepaid expenses and other current assets		40,866				27,300
Total current assets		1,474,156				1,430,995
Deferred income taxes, net		114,268				115,031
Goodwill		71,763				67,241
Intangible assets, net		54,653				55,376
Property, plant and equipment, net		621,352				588,375
Other assets		43,256				32,246
Total assets	$	2,379,448			$	2,289,264
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	41,522			$	35,385
Accrued expenses and other current liabilities		170,790				152,048
Income taxes payable		4,640				17,586
Total current liabilities		216,952				205,019
Other long-term liabilities and deferred income taxes		57,944				59,774
Total liabilities		274,896				264,793
Commitments and contingencies
IPG Photonics Corporation equity:
Common stock, $0.0001 par value, 175,000,000 shares authorized; 56,905,313 and 42,329,918 shares issued and outstanding, respectively, at June 30, 2025; 56,632,974 and 42,548,561 shares issued and outstanding, respectively, at December 31, 2024.		6				6
Treasury stock, at cost, 14,575,395 and 14,084,413 shares held at June 30, 2025 and December 31, 2024, respectively.		(1,535,525	)			(1,505,321	)
Additional paid-in capital		1,053,080				1,035,285
Retained earnings		2,624,231				2,613,868
Accumulated other comprehensive loss		(37,240	)			(119,367	)
Total IPG Photonics Corporation stockholders' equity		2,104,552				2,024,471
Total liabilities and equity	$	2,379,448			$	2,289,264

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
	Six Months Ended June 30,
		2025				2024
	(In thousands)
Cash flows from operating activities:
Net income	$	10,363			$	44,253
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		31,167				31,506
Provisions for inventory, warranty & bad debt		22,080				30,365
Other		17,162				(8	)
Changes in assets and liabilities that (used) provided cash, net of acquisitions:
Accounts receivable and accounts payable		(14,061	)			39,736
Inventories		(23,837	)			17,041
Other		(31,645	)			(54,839	)
Net cash provided by operating activities		11,229				108,054
Cash flows from investing activities:
Purchases of and deposits on property, plant and equipment		(40,176	)			(52,270	)
Proceeds from sales of property, plant and equipment		563				28,274
Purchases of short-term investments		(579,814	)			(301,541	)
Proceeds from short-term investments		357,859				633,993
Other		52				188
Net cash (used in) provided by investing activities		(261,516	)			308,644
Cash flows from financing activities:
Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock options		(4,253	)			1,792
Purchase of treasury stock net of excise tax, at cost		(30,204	)			(212,020	)
Net cash used in financing activities		(34,457	)			(210,228	)
Effect of changes in exchange rates on cash and cash equivalents		23,888				(604	)
Net (decrease) increase in cash and cash equivalents		(260,856	)			205,866
Cash and cash equivalents — Beginning of period		620,040				514,674
Cash and cash equivalents — End of period	$	359,184			$	720,540
Supplemental disclosures of cash flow information:
Cash paid for interest	$	8			$	94
Cash paid for income taxes	$	32,918			$	34,165

IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)

Use of Non-GAAP Adjusted Financial Information

We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. These measures should not be considered as a substitute for, or superior to, GAAP financial measures. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company.

We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual changes, including acquisition and integration charges and amortization of acquisition-related intangibles.

We define adjusted gross margin as adjusted gross profit divided by total revenue.

We define adjusted operating income as reported income from operations, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define EBITDA as net income plus interest expense (income), provision for income taxes, depreciation expense, and amortization expense.

We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual changes, and other adjustments that the Company believes appropriate, including amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.

We define adjusted EPS as adjusted net income divided by the weighted-average diluted shares outstanding.

We define adjusted tax rate as the GAAP tax rate, adjusted for discrete tax items and the net impact of non-GAAP adjustments.

Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. Specifically, these non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts.

In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) special inventory provisions, (ii) amortization of acquisition-related intangibles, (iii) restructuring charges, (iv) acquisition and integration charges, (v) goodwill and intangible asset impairments, (vi) foreign exchange gains/losses, (vii) interest income, (viii) benefit (provision) from income taxes, (ix) depreciation, (x) amortization, (xi) stock-based compensation, (xii) gain/loss on disposal of assets/divestiture, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.

We have not provided a quantitative reconciliation of forward-looking Non-GAAP adjusted earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures because we are unable to estimate with reasonable certainty the ultimate timing or amount of certain significant items without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing and/or amount of various items that would impact adjusted earnings per diluted share and adjusted EBITDA. This includes items that have not yet occurred, are out of the Company’s control, cannot be reasonably predicted and/or for which there would not be any meaningful adjustment or difference. For the same reasons, the Company is unable to address the probable significance of the unavailable information.

Our non-GAAP tax provision for the fiscal second quarter of 2025 is 14%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.

IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASUREMENTS (UNAUDITED)

Reconciliation of Gross Profit to Adjusted Gross Profit, Adjusted Gross Margin

	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
	(in thousands, except per share data)
Gross profit	$	93,573			$	96,186			$	183,385			$	193,722
Gross margin		37.3	%			37.3	%			38.3	%			38.0	%
Amortization of acquisition-related intangibles		1,061				440				2,077				928
Acquisition and integration charges		260				—				482				—
Adjusted gross profit	$	94,894			$	96,626			$	185,944			$	194,650
Adjusted gross margin		37.8	%			37.5	%			38.9	%			38.2	%

Reconciliation of Operating Income to Adjusted Operating Income

	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
	(in thousands, except per share data)
Operating income	$	104			$	12,040			$	1,931			$	31,140
Amortization of acquisition-related intangibles		2,594				1,377				5,096				2,802
Acquisition and integration charges		1,068				—				2,059				—
Loss on foreign exchange		3,098				3,244				5,509				4,919
Gain on sale of assets		—				—				—				(6,776	)
Adjusted operating income	$	6,864			$	16,661			$	14,595			$	32,085

Reconciliation of Net income to Adjusted EBITDA

	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
	(in thousands, except per share data)
Net income	$	6,605			$	20,154			$	10,363			$	44,253
Interest income, net		(8,001	)			(12,778	)			(15,445	)			(26,955	)
Provision for income taxes		1,666				4,858				8,523				14,361
Depreciation		12,172				13,309				23,728				27,236
Amortization		3,654				2,010				7,439				4,270
EBITDA	$	16,096			$	27,553			$	34,608			$	63,165
Stock based compensation		11,287				8,570				22,054				18,302
Acquisition and integration charges		1,068				—				2,059				—
Loss on foreign exchange		3,098				3,244				5,509				4,919
Gain on sale of assets		—				—				—				(6,776	)
Adjusted EBITDA	$	31,549			$	39,367			$	64,230			$	79,610

Reconciliation of GAAP to Non-GAAP Net Income, and GAAP to Non-GAAP Net Income per Share, Diluted

	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
	(in thousands, except per share data)
Net income	$	6,605			$	20,154			$	10,363			$	44,253
Amortization of acquisition-related intangibles		2,594				1,377				5,096				2,802
Acquisition and integration charges		1,068				—				2,059				—
Loss on foreign exchange		3,098				3,244				5,509				4,919
Gain on sale of assets		—				—				—				(6,776	)
Certain discrete tax items		275				(85	)			4,889				1,912
Tax impact of non-GAAP adjustments		(710	)			(1,075	)			(1,858	)			(342	)
Adjusted net income	$	12,930			$	23,615			$	26,058			$	46,768
Adjusted net earnings per diluted share	$	0.30			$	0.52			$	0.61			$	1.03
Weighted average diluted shares outstanding		42,577				45,012				42,720				45,601

Reconciliation of GAAP to Non-GAAP Effective Tax Rate

	Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
Tax rate		20	%			19	%			45	%			25	%
Discrete tax items		(3	)%			—	%			(26	)%			(3	)%
Net impact of non-GAAP adjustments		(3	)%			1	%			(2	)%			(1	)%
Adjusted tax rate		14	%			20	%			17	%			21	%

During the first fiscal quarter of 2025, the Company refined its methodology to report non-GAAP measures. The change does not impact the Company’s financial position, cash flows, or GAAP consolidated results of operations. Prior period non-GAAP financial measures and the associated GAAP to non-GAAP reconciliations presented in this press release have been recast to conform to the current presentation.

FAQ

What were IPG Photonics (IPGP) Q2 2025 earnings results?

IPG reported revenue of $250.7 million (down 3% YoY), earnings per share of $0.16 (down 64% YoY), and adjusted EBITDA of $31.5 million.

What is IPG Photonics' revenue guidance for Q3 2025?

IPG expects Q3 2025 revenue between $225-255 million with adjusted earnings per share of $0.05-0.35.

How did IPG Photonics' regional sales perform in Q2 2025?

Sales increased 14% in Asia, decreased 4% in North America, and declined 24% in Europe year-over-year.

What percentage of IPG Photonics' revenue came from materials processing in Q2 2025?

Materials processing sales accounted for 85% of total revenue but decreased 6% year-over-year.

How much did IPG Photonics spend on share repurchases in Q2 2025?

IPG spent $30 million on share repurchases during the second quarter.